New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.
-
Published:2023-11
Issue:
Volume:
Page:101820
-
ISSN:1936-5233
-
Container-title:Translational Oncology
-
language:en
-
Short-container-title:Translational Oncology
Author:
Kiesslich Tobias,
Mayr Christian,
Bekric DinoORCID,
Neureiter DanielORCID
Subject
Cancer Research,Oncology